Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1689602, 16 pages
http://dx.doi.org/10.1155/2016/1689602
Research Article

Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1

1Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
2Beijing Aortic Disease Center, Anzhen Hospital, Capital Medical University, Beijing 100029, China
3Department of Biomedical Engineering, Fourth Military Medical University, Xi’an 710032, China
4School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China
5College of Life Science, Northwest University, Xi’an 710069, China
6Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China

Received 29 April 2015; Accepted 6 September 2015

Academic Editor: Vladimir Jakovljevic

Copyright © 2016 Liming Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Hausenloy and D. M. Yellon, “Myocardial ischemia-reperfusion injury: a neglected therapeutic target,” The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Müller, L. V. Hryshko, and N. S. Dhalla, “Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury,” International Journal of Cardiology, vol. 164, no. 1, pp. 39–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. J. Maxwell and G. Y. H. Lip, “Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options,” International Journal of Cardiology, vol. 58, no. 2, pp. 95–117, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Petrosillo, F. M. Ruggiero, N. Di Venosa, and G. Paradies, “Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin,” The FASEB Journal, vol. 17, no. 6, pp. 714–716, 2003. View at Google Scholar · View at Scopus
  5. J. L. Zweier and M. A. H. Talukder, “The role of oxidants and free radicals in reperfusion injury,” Cardiovascular Research, vol. 70, no. 2, pp. 181–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tillhon, L. M. Guamán Ortiz, P. Lombardi, and A. I. Scovassi, “Berberine: new perspectives for old remedies,” Biochemical Pharmacology, vol. 84, no. 10, pp. 1260–1267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Imanshahidi and H. Hosseinzadeh, “Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine,” Phytotherapy Research, vol. 22, no. 8, pp. 999–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-L. Kuo, C.-W. Chi, and T.-Y. Liu, “The anti-inflammatory potential of berberine in vitro and in vivo,” Cancer Letters, vol. 203, no. 2, pp. 127–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. R. Stermitz, P. Lorenz, J. N. Tawara, L. A. Zenewicz, and K. Lewis, “Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1433–1437, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-H. Zeng, X.-J. Zeng, and Y.-Y. Li, “Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy,” The American Journal of Cardiology, vol. 92, no. 2, pp. 173–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Zhang, D. Ma, Y. Wang et al., “Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice,” Food and Chemical Toxicology C, vol. 74, pp. 225–232, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Gao, Y. Gao, Y.-F. Liu, L. Wang, and Y.-J. Li, “Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat,” Neuropsychiatric Disease and Treatment, vol. 10, pp. 2139–2145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Chi, L. Peng, X. Hu, N. Pan, and Y. Zhang, “Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages,” International Journal of Molecular Medicine, vol. 34, no. 1, pp. 283–290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Gao, Y.-Q. Tang, D.-Z. Dai et al., “Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influx,” Acta Pharmacologica Sinica, vol. 33, no. 5, pp. 625–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-Y. Qi, Y. Feng, D.-Z. Dai, N. Li, Y.-S. Cheng, and Y. Dai, “CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity,” Acta Pharmacologica Sinica, vol. 31, no. 2, pp. 165–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yang, W. Duan, Y. Li et al., “New role of silent information regulator 1 in cerebral ischemia,” Neurobiology of Aging, vol. 34, no. 12, pp. 2879–2888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Yang, W. Duan, Y. Li et al., “Novel role of silent information regulator 1 in myocardial ischemia,” Circulation, vol. 128, no. 20, pp. 2232–2240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., “Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,” Science, vol. 303, no. 5666, pp. 2011–2015, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Daitoku, M. Hatta, H. Matsuzaki et al., “Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 27, pp. 10042–10047, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhu, X. Guo, G. Mao et al., “Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1,” Phytotherapy Research, vol. 27, no. 3, pp. 417–421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Gomes, F. V. Duarte, P. Nunes et al., “Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 2, pp. 185–195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Yu, F. Li, G. Zhao et al., “Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling,” Apoptosis, vol. 20, no. 6, pp. 796–810, 2015. View at Publisher · View at Google Scholar
  23. Y. Yang, W. Duan, Z. Jin et al., “JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury,” Journal of Pineal Research, vol. 55, no. 3, pp. 275–286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Chen, G. Li, F. Geng et al., “Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats,” Apoptosis, vol. 19, no. 6, pp. 946–957, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Rizk, S. A. El-Maraghy, and N. N. Nassar, “A novel role for SIRT-1 in L-Arginine protection against STZ induced myocardial fibrosis in rats,” PLoS ONE, vol. 9, no. 12, Article ID e114560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Su, L. Ji, W. Xing et al., “Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein,” Journal of Cellular and Molecular Medicine, vol. 17, no. 1, pp. 181–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Lin, H. Wang, J. Li et al., “kappa-Opioid receptor stimulation modulates TLR4/NF-kappaB signaling in the rat heart subjected to ischemia-reperfusion,” Cytokine, vol. 61, no. 3, pp. 842–848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Wu, B. Zhang, R. Fan et al., “U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart,” Cytokine, vol. 56, no. 2, pp. 503–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Zhang, S. Yang, and J. Du, “Protective effects of berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 849783, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-J. Zhang, S.-H. Yang, M.-H. Li et al., “Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy,” Clinical and Experimental Pharmacology & Physiology, vol. 41, no. 12, pp. 995–1002, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M.-H. Li, Y.-J. Zhang, Y.-H. Yu et al., “Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy,” European Journal of Pharmacology, vol. 728, no. 1, pp. 67–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Lv, X. Yu, Y. Wang et al., “Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression,” PLoS ONE, vol. 7, no. 10, Article ID e47351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-X. Lv, X.-H. Yu, H.-D. Wang et al., “Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-alpha-caspase signaling pathway,” Chinese Journal of Integrative Medicine, vol. 19, no. 6, pp. 424–431, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Chang, M. Zhang, J. Li et al., ““Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart,” Cardiovascular Drugs and Therapy, vol. 26, no. 6, pp. 467–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. O. Germoush and A. M. Mahmoud, “Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 7, pp. 1103–1109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Lefer, X.-L. Ma, A. Weyrich, and D. J. Lefer, “Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury,” Agents and Actions Supplements, vol. 41, pp. 127–135, 1993. View at Google Scholar · View at Scopus
  37. Y. Tian, H. Li, P. Liu et al., “Captopril pretreatment produces an additive cardioprotection to isoflurane preconditioning in attenuating myocardial ischemia reperfusion injury in rabbits and in humans,” Mediators of Inflammation, vol. 2015, Article ID 819232, 12 pages, 2015. View at Publisher · View at Google Scholar
  38. Y. Yang, W. Duan, Y. Lin et al., “SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury,” Free Radical Biology & Medicine, vol. 65, pp. 667–679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-P. Hsu, P. Zhai, T. Yamamoto et al., “Silent information regulator 1 protects the heart from ischemia/reperfusion,” Circulation, vol. 122, no. 21, pp. 2170–2182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Zhang, X. Liu, Z.-G. She et al., “Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 109, no. 5. article 434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Winnik, J. Auwerx, D. A. Sinclair, and C. M. Matter, “Protective effects of sirtuins in cardiovascular diseases: from bench to bedside,” European Heart Journal, 2015. View at Publisher · View at Google Scholar
  42. M. Vinciguerra, M. P. Santini, C. Martinez et al., “mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart,” Aging Cell, vol. 11, no. 1, pp. 139–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ruscica, M. Gomaraschi, G. Mombelli et al., “Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus,” Journal of Clinical Lipidology, vol. 8, no. 1, pp. 61–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Sola, R.-M. Valls, J. Puzo et al., “Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial,” PLoS ONE, vol. 9, no. 8, Article ID e101978, 2014. View at Publisher · View at Google Scholar · View at Scopus